and Molecular Diagnostics,
8th Edition by Nader Rifai, PhD
Chapters 1 - 49
,Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 8th Edition Test Bank
vr vr vr vr vr vr vr vr
vr
vr vr
Table of contents:
vr vr
I. Principles Of Laboratory Medicine
vr vr vr vr
Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
vr vr vr vr vr vr vr vr
Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
vr vr vr vr vr vr vr vr vr vr vr
Chapter 3. Clinical Evaluation of Methods
vr vr vr vr vr
Chapter 4. Evidence-Based Laboratory Medicine
vr vr vr vr
Chapter 5. Establishment and Use of Reference Values
vr vr vr vr vr vr vr
Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
vr vr vr vr vr vr vr vr
Chapter 7. Quality Management
vr vr vr
II. Analytical Techniques And Instrumentation
vr vr vr vr
Chapter 8. Principles of Basic Techniques and Laboratory Safety
vr vr vr vr vr vr vr vr
Chapter 9. Optical Techniques
vr vr vr
Chapter 10. Electrochemistry and Chemical Sensors
vr vr vr vr vr
Chapter 11. Electrophoresis
vr vr
Chapter 12. Chromatography
vr vr
Chapter 13. Mass Spectrometry
vr vr vr
Chapter 14. Enzyme and Rate Analyses
vr vr vr vr vr
Chapter 15. Immunochemical Techniques
vr vr vr
Chapter 16 Automation vr vr
Chapter 17. Point-of-Care Instrumentation
vr vr vr
III. Analytes
v r
Chapter 18. Amino Acids, Peptides, and Proteins
vr vr vr vr vr vr
Chapter 19. Serum Enzymes
vr vr vr
Chapter 20. Tumor Markers and Cancer Genes
vr vr vr vr vr vr
Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
vr vr vr vr vr vr vr vr vr vr vr
Chapter 22. Carbohydrates
vr vr
Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
vr vr vr vr vr vr vr vr vr
Chapter 24. Electrolytes and Blood Gases
vr vr vr vr vr
Chapter 25. Hormones vr vr
Chapter 26. Catecholamines and Serotonin
vr v r vr vr
Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
vr v r vr vr vr vr
Chapter 28. Hemoglobin, Iron, and Bilirubin
vr vr vr vr vr
Chapter 29. Porphyrins and Porphyrias
vr vr vr vr
Chapter 30. Therapeutic Drugs and Their Management
vr vr vr vr vr vr
Chapter 31. Clinical Toxicology
vr vr vr
Chapter 32. Toxic Metals
vr v r vr
IV. Pathophysiology
v r
Chapter 33. Diabetes vr vr
,Chapter 34. Cardiovascular Disease
vr v r vr
Chapter 35. Kidney Disease
vr vr vr
Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
vr v r vr vr vr vr vr vr vr vr
Chapter 37. Liver Disease
vr vr vr vr
Chapter 38. Gastrointestinal and Pancreatic Diseases
vr v r vr vr vr
Chapter 39. Disorders of Bone and Mineral Metabolism
vr vr vr vr vr vr vr vr
Chapter 40. Disorders of the Pituitary Gland
vr vr vr vr vr vr vr
Chapter 41. Disorders of the Adrenal Cortex
vr v r vr vr vr vr
Chapter 42. Thyroid Disorders
vr v r vr
Chapter 43. Reproduction-Related Disorders
vr v r vr
Chapter 44. Pregnancy and Prenatal Testing
vr vr vr vr vr vr
Chapter 45. Newborn Screening and Inborn Errors of Metabolism
vr v r vr vr vr vr vr vr
Chapter 46. Pharmacogenetics
vr vr
V. Molecular Diagnostics
v r vr
Chapter 47. Principles of Molecular Biology
vr vr vr vr vr
Chapter 48. Nucleic Acid Techniques and Applications
vr vr vr vr vr vr
Chapter 49. Genomes and Nucleic Acid Alterations
vr vr vr vr vr vr
, Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
vr vr vr vr vr vr vr vr
TestBank
vr r
v
MULTIPLE CHOICE vr
1. An individual working in a clinical chemistry laboratory is married to a sales
vr vr vr vr vr vr vr vr vr vr vr vr
representative who works for a company that sells chemistry laboratory supplies. When
vr vr vr vr vr vr vr vr vr vr vr vr
the laboratory manager requests a list of needed supplies, cost of supplies, and vendors,
vr vr vr vr vr vr vr vr vr vr vr vr vr vr
this individual onlyrecommends the spouse’s company as the vendor. This is considered
vr vr vr vr vr vr vr vr vr vr vr vr vr
to be a(n):
vr vr vr
a. accounting issue. vr
b. possible conflict of interest. vr vr vr
c. maintenance of confidentiality issue. vr vr vr
d. problem with resource allocation. vr vr vr
ANS: B vr
Concern has been raised over the interrelationships between practitioners in the medical
vr vr vr vr vr vr vr vr vr vr vr
fieldand commercial suppliers of drugs, devices, equipment, etc., to the medical
vr vr vr vr vr vr vr vr vr vr vr vr
profession.
vr
Similarly, relationships have been scrutinized between clinical laboratorians and
vr vr vr vr vr vr vr vr
manufacturers and providers of diagnostic equipment and supplies. These concerns led the
vr vr vr vr vr vr vr vr vr vr vr vr
National Institutes of Health (NIH) in 1995 to require official institutional review of
vr vr vr vr vr vr vr vr vr vr vr vr vr
financial disclosure by researchers and management of situations in which disclosure
vr vr vr vr vr vr vr vr vr vr vr
indicates potentialconflicts of interest.
vr vr vr vr vr
DIF: 1 REF: vr vr vr Page 4-5 vr OBJ: 6 | 7 vr vr vr
2. A patient visits her physician stating that her prescribed painkiller is not working to
vr vr vr vr vr vr vr vr vr vr vr vr vr
reduce the pain following her recent surgery. A friend of the patient claims that the
vr vr vr vr vr vr vr vr vr vr vr vr vr vr vr
same painkiller“worked wonders” to reduce her pain after the same surgery. The
vr vr vr vr vr vr vr vr vr vr vr vr vr
physician states that the difference in the effect of the drug might be caused by
vr vr , vr vr vr vr vr vr vr vr vr vr vr vr vr
which is studied in pharmacogenetics.
vr vr vr vr vr
a. epidemiology
b. an inherited disease vr vr
c. a conflict of interest
vr vr vr
d. a genetic variation in drug-metabolizing enzymes
vr vr vr vr vr
ANS: D vr
Pharmacogenetics is the study of the genetic variation of drug metabolism vr vr vr vr vr vr vr vr vr vr
betweenindividuals.
vr vr
DIF: 1 REF: vr vr vr Page 3 vr OBJ: 1 vr
3. John works in a molecular diagnostics laboratory and receives a blood sample that has
vr vr vr vr vr vr vr vr vr vr vr vr vr
the name of a close friend printed on the bar-coded label. The genetic test that is
vr vr vr vr vr vr vr vr vr vr vr vr vr vr vr vr
ordered on thefriend’s sample would provide diagnostic information about a disorder
vr vr vr vr vr vr vr vr vr vr vr vr
that has a poor prognosis, and the test is usually performed by John. He asks a fellow
vr vr vr vr vr vr vr vr vr vr vr vr vr vr vr vr vr
employee to analyzethe sample for him and not divulge the results. This ethical issue
vr vr vr vr vr vr vr vr vr vr vr vr vr vr vr
concerns:
vr
a. confidentiality of patient genetic and medical information. vr vr vr vr vr vr
b. a conflict of interest.
vr vr vr
c. resource allocation. vr
d. diagnostic accuracy. vr